In aneuploid cancers, activation of the cGAS-STING pathway does not generate the expected downstream canonical NFκB and type I interferon signaling, but rather drives the non-canonical NFκB signaling cascade more typically seen in myeloid-derived cells, which the authors speculate may represent a form of immune mimicry (79). The gene discussed is NFKB1; the disease is cancer.